Antoni Wiedlocha funded by the EEA Poland-Norway grants
Antoni Wiedlocha
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Małecki JM, Weirich S, Ramirez-Garrastacho M, Hagen L, Al-Egly J, Anonsen JH, Schroer L, Herrera MC, Davydova E, Slupphaug G, Jeltsch A, Falnes PØ(2025) Identification of substrates and sequence requirements for CARNMT1-mediated histidine methylation of C3H zinc fingers J Biol Chem, 110335(in press) DOI 10.1016/j.jbc.2025.110335, PubMed 40473212
Vigfusdottir J, Breivik E, Henden BO, Jonsbu E, Lien L, Stenmark H, Mork E(2025) Difficulties in emotion regulation among patients with substance use disorder and a history of exposure to traumatic events: the role of PTSD symptoms, emotional avoidance, shame, and guilt Eur J Psychotraumatol, 16(1), 2509385 DOI 10.1080/20008066.2025.2509385, PubMed 40470803
Li Y, Wang Y, Cengiz A, Jin KX, Castroviejo BC, Lin X, Indahl M, Zuo R, Skuland T, Fosslie M, Biba M, Wu X, Fedorcsak P, Bjørås M, Filipczyk A, Dahl JA, Greggains GD, Au KF, Klungland A(2025) The RNA m6A landscape during human oocyte-to-embryo transition EMBO J(in press) DOI 10.1038/s44318-025-00474-5, PubMed 40467862